You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
賢豐控股(002141.SZ):擬對史紀生物增資4200萬元

格隆匯8月2日丨賢豐控股(002141.SZ)公佈,為進一步支持控股子公司成都史紀生物製藥有限公司(簡稱“史紀生物”)的研發項目推進,增強史紀生物的研發實力,賢豐控股股份有限公司擬以自有資金與遼寧成大生物股份有限公司(簡稱“成大生物”)按持股比例對史紀生物進行增資,總增資額6000萬元(按持股比例公司增資4200萬元,成大生物增資1800萬元),首期出資2000萬元,後續根據研發項目進展及資金需求安排出資,並同意史紀生物在本次增資範圍內與核心團隊持股平台共同設立研發子公司,核心團隊持股平台認繳研發子公司股份比例不超過10%,可延期3年出資。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account